Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer

This study has been completed.
Information provided by:
AGO Study Group Identifier:
First received: January 29, 2005
Last updated: November 13, 2006
Last verified: January 2005